A Clinical Trial of Entinostat in Combination With Nivolumab for Patients With Previously Treated Unresectable or Metastatic Cholangiocarcinoma and Pancreatic Adenocarcinoma
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- 54
Summary
- Conditions
- Cholangiocarcinoma
- Metastatic Pancreatic Cancer
- Pancreatic Cancer
- Previously Treated Unresectable or Metastatic Cholangiocarcinoma and Pancreatic Cancer
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: Non-RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 100 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03250273
- Collaborators
- Syndax Pharmaceuticals
- Bristol-Myers Squibb
- Investigators
- Principal Investigator: Nilofer Azad, MD Johns Hopkins University
Get Well Soon